Evaluation of early post-natal pig mammary gland development and human breast cancer gene expression

2021 ◽  
Author(s):  
Shelby Smith ◽  
Amber Stone ◽  
Hannah Oswalt ◽  
Lewis Vaughan ◽  
Farzana Ferdous ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Gene Expression ◽  
Mammary Gland ◽  
Human Breast Cancer ◽  
Mammary Gland Development ◽  
Cancer Gene ◽  
Human Breast ◽  
Gland Development ◽  
Breast Cancer Gene

scholarly journals Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression

2009 ◽  
Vol 11 (3) ◽  
Author(s):  
Cecilia Williams ◽  
Luisa Helguero ◽  
Karin Edvardsson ◽  
Lars-Arne Haldosén ◽  
Jan-Åke Gustafsson
Keyword(s):  
Breast Cancer ◽  
Gene Expression ◽  
Stem Cell ◽  
Human Breast Cancer ◽  
Mammary Epithelial ◽  
Cancer Gene ◽  
Human Breast ◽  
Epithelial Stem Cell ◽  
Breast Cancer Gene

scholarly journals Histone Deacetylase Inhibitors and Microtubule Inhibitors Induce Apoptosis in Feline Luminal Mammary Carcinoma Cells

Animals ◽  
2021 ◽  
Vol 11 (2) ◽  
pp. 502
Author(s):  
Filipe Almeida ◽  
Andreia Gameiro ◽  
Jorge Correia ◽  
Fernando Ferreira
Keyword(s):  
Breast Cancer ◽  
Gene Expression ◽  
Cell Line ◽  
Cell Lines ◽  
Mammary Carcinoma ◽  
Human Breast Cancer ◽  
Histone Deacetylase Inhibitors ◽  
Trichostatin A ◽  
Human Breast ◽  
Antitumor Effects

Feline mammary carcinoma (FMC) is the third most common type of neoplasia in cats, sharing similar epidemiological features with human breast cancer. In humans, histone deacetylases (HDACs) play an important role in the regulation of gene expression, with HDAC inhibitors (HDACis) disrupting gene expression and leading to cell death. In parallel, microtubules inhibitors (MTIs) interfere with the polymerization of microtubules, leading to cell cycle arrest and apoptosis. Although HDACis and MTIs are used in human cancer patients, in cats, data is scarce. In this study, we evaluated the antitumor properties of six HDACis (CI-994, panobinostat, SAHA, SBHA, scriptaid, and trichostatin A) and four MTIs (colchicine, nocodazole, paclitaxel, and vinblastine) using three FMC cell lines (CAT-MT, FMCp, and FMCm), and compared with the human breast cancer cell line (SK-BR-3). HDACis and MTIs exhibited dose-dependent antitumor effects in FMC cell lines, and for all inhibitors, the IC50 values were determined, with one feline cell line showing reduced susceptibility (FMCm). Immunoblot analysis confirmed an increase in the acetylation status of core histone protein HDAC3 and flow cytometry showed that HDACis and MTIs lead to cellular apoptosis. Overall, our study uncovers HDACis and MTIs as promising anti-cancer agents to treat FMCs.

Sign in / Sign up

Export Citation Format

Share Document